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Differentiation of stem cells is an important strategy for regeneration of defective tissue in stem cell therapy. Bone morphogenetic
protein-2 (BMP-2) is a well-known osteogenic differentiation factor that stimulates stem cell signaling pathways by activating
transmembrane type I and type II receptors. However, BMPs have a very short half-life and may rapidly lose their bioactivity.
Thus, a BMP delivery system is required to take advantage of an osteoinductive effect for osteogenic differentiation. Previously,
BMP delivery has been designed and evaluated for osteogenic differentiation, focusing on carriers and sustained release system for
delivery of BMPs. The effect of the delivery mode in cell culture plate on osteogenic differentiation potential was not evaluated.
Herein, to investigate the effect of delivery mode on osteogenic differentiation of BM-MSCs in this study, we fabricated bottom-up
release and top-down release systems for culture plate delivery of BMP-2. And also, we selected Arg-Gly-Asp- (RGD-) conjugated
alginate hydrogel for BMP-2 delivery because alginate is able to release BMP-2 in a sustained manner and it is a biocompatible
material. After 7 days of culture, the bottom-up release system in culture plate significantly stimulated alkaline phosphate activity
of human bone marrow-mesenchymal stem cells. The present study highlights the potential value of the tool in stem cell therapy.
1. Introduction
An in vitro differentiation process to obtain specific cell type
from stem cells is required for stem cell therapy. Stem cells can
be manipulated in vitro under specific conditions that favor
differentiation towards a designated somatic cell type [1].
Many studies have demonstrated manipulative techniques
to direct stem cell differentiation through use of defined
media, substrates and growth factors [2]. In particular, bone
morphogenetic protein-2 (BMP-2) is a well-known inductive
growth factor for osteogenic differentiation of various stem
cells [3]. BMP-2 binds to microdomains on the cellular
surface related to biological signal pathways, such as cognate
receptors, to induce osteogenic differentiation [4]. Thus, the
probability of BMP-2 binding to surface receptors should be
maximized to enhance efficacy of osteogenic differentiation
during BMP-2 treatment process in vitro.
Protein delivery system is a promising method for local-
ized and sustained delivery of biologically active BMP-2
at the target sites [5]. Conventional methods involve the
daily addition of BMP-2 to the culture medium and BMP-
2 is assumed to be homogeneous as well as sufficient in
the medium [6]. However, only a small amount reaches
the cellular microdomains related to the biological signal
pathways because of Brownian motion of BMP-2 in the
culture medium. In contrast, BMP-2 released from a matrix
utilizing a protein delivery system could efficiently bind
to receptors on the cultured cells. However, such delivery
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systems rarely focus on monolayer cultures subject to con-
ventional techniques. Previous studies have not compared the
effect of BMP-2 delivery modes on stem cells in a monolayer
culture system that provides convenience and speed to obtain
a large number of desired cells, such as osteocytes.
The purpose of this study was to investigate the effects
of BMP-2 delivery mode on the osteogenic differentiation
of human bone marrow-derived mesenchymal stem cells
(BM-MSCs). To that end, BMP-2 was loaded to Arg-Gly-Asp
(RGD) peptide-conjugated alginate hydrogel. We selected
alginate as a base material for BMP-2 delivery in this study
because alginate has valuable properties such as biocompati-
bility and gel-forming properties via ionic crosslinking using
calcium in mild condition. In addition, this reaction is rapid
and selective and produces high yields.Thus, this can be used
as a carrier of BMP-2 and to create a suitable environment
for cell culture. Human BM-MSCs were induced by using a
bottom-up and top-down release system and the cells were
characterized in terms of alkaline phosphatase (ALP) activity
and differentiation. The results may provide a useful tool for
expanding the potential applications of stem cell therapy.
2. Methods and Materials
2.1. Synthesis of Peptide-Modified Alginate. Sodium alginate
(𝑀
𝑤
= 200,000–300,000; FMC Biopolymer, Philadelphia,
PA) was dissolved in a 2-(N-morpholino)ethanesulfonic acid
(MES) buffer at room temperature (pH = 6.5, 0.3M NaCl).
A peptide with the (glycine)
4
-arginine-glycine-aspartic acid-
alanine-(serine)
2
-lysine (G4RGDASSK) sequence (Anygen,
Seoul, Republic of Korea) was added to the alginate solution
in the presence of N-hydroxysulfosuccinimide (sulfo-NHS;
Pierce, Rockford, IL) and 1-ethyl-3-(dimethylaminopropyl)
carbodiimide (EDC, Sigma-Aldrich, St. Louis, MO). The
peptide-modified alginate was purified by extensive dialysis
with distilled water for 5 days (𝑀
𝑤
cut-off = 3,500) and acti-
vated charcoal treatment and then sterilized with a 0.22𝜇m
filter. The degree of substitution (DS) of the peptide was
determined with the number of peptides per 100 uronic acid
residues in the alginate chain. In this study, the DS was 0.15
[7].
2.2. Preparation of Hydrogels and Encapsulation of BMP-2.
The purified and lyophilized RGD-modified alginate (60mg)
was dissolved in 𝛼-MEM (3mL) and mixed with the Chinese
Hamster Ovary (CHO) cell-derived recombinant human
BMP-2 (R&D Systems, Minneapolis, MN). A calcium sulfate
(CaSO
4
) solution (20%w/v, 120𝜇L) was added to a second
syringe. The two syringes were connected with a female
connector, and the contents were quickly mixed. An alginate
solution containing CaSO
4
formed a gel at 37∘C for 20min.
The gel was used to punch out discs (8mm diameter; 0.5, 1,
and 2mm thickness) used for release test of BMP-2 and for
culture of cells.
2.3. Determination of the Kinetics of BMP-2 Release from
RGD-Alginate Hydrogel Discs. To determine the degree of
BMP-2 release from RGD-alginate hydrogel discs (2%w/v)
with 0.5, 1, and 2mm thickness, BMP-2-loaded scaffolds were
sunk in 24-well culture plates containing 1mL phosphate-
buffered saline (PBS, pH 7.4; Sigma) and the culture plates
were incubated at 37∘C without agitation. At predetermined
times, enzyme-linked immunosorbent assay (ELISA) was
done to determine the kinetics of BMP-2 release from RGD-
alginate hydrogel discs with various thicknesses. At each
time point, supernatant was collected and the culture plates
were replenished with fresh buffer. The amount of BMP-2 in
the supernatants was measured using an ELISA kit (human
beta BMP-2 Duoset; R&D Systems). Briefly, ELISA plates
(NUNC, Polylabo, Strasbourg, France) were coated with the
capture monoclonal antibody and then blocked with the
bovine serum albumin (1 w/v%) and sucrose (5 w/v%) for 1
hour. After appropriately diluted supernatants were added,
bound-BMP-2 was detected with biotin-conjugated anti-
human BMP-2 polyclonal antibody. Streptavidin-conjugated
horseradish peroxidase was then added to the plates. Enzyme
substrate (tetramethylbenzidine and peroxide) was treated
for 20 minutes, and the reaction was stopped by adding an
acidic solution. Absorbance was measured at 450 nm range
of PowerWave X340 plate reader (Bio-TEK Instrument, Inc.,
Winooski, VT). The amount of BMP-2 was calculated from
a calibration curve based on known concentrations of BMP-
2. Experiments were performed with five replicates of each
supernatant.
2.4. Cell Culture andDifferentiation. Human BM-MSCswere
purchased (Lonza Ltd., Walkersville, MD) and cultured in
accordance with a previously described method [8]. Briefly,
cells were maintained in 𝛼-MEM (Gibco BRL, Grand Island,
NY) supplemented with 10% (v/v) fetal bovine serum (FBS;
Gibco BRL), 2mM L-glutamine (Gibco BRL), 100 units/mL
penicillin (Gibco BRL), and 0.1mg/mL streptomycin (Gibco
BRL). In this study, BM-MSCs were used after three to
five passages. The stem cell markers (CD 44 (95.39%),
CD 73 (93.13%), CD 90 (98.60%), and CD 105 (94.71%))
for BM-MSCs were analyzed by fluorescence activated cell
sorting (FACS) analysis which characterized BM-MSCs at
passage 5 by flow cytometry histograms (see Supplemen-
tary Figure 1 in Supplementary Material available online at
https://doi.org/10.1155/2017/7859184).
To determine RGD modification of alginate, the BM-
MSCswere seeded onto the surfaces of alginate hydrogel discs
at density of 2× 104 cells/cm2.Thediscswere placed in 24-well
culture plates and incubated at 37∘C under 5% CO
2
atmo-
sphere. After a 24 h culture period, discs were washed with
PBS to remove nonadhered cells, and then photographs of
the BM-MSCs adhering to the surface of the discs were taken
using an optical microscope (Olympus, Tokyo, Japan). For
the osteogenic differentiation of BM-MSCs, the BM-MSCs
and RGD-modified alginate hydrogel discs containing BMP-
2 (2 𝜇g/disc) were applied as shown in Figures 2 and 3. Briefly,
the BM-MSCs were seeded onto RGD-modified alginate
hydrogel discs with BMP-2 and cultured with 𝛼-MEM for 7
days to obtain the bottom-up release system. To construct the
top-down release system, BM-MSCs were seeded onto RGD-
modified alginate hydrogel discs without BMP-2 and RGD-
modified alginate hydrogel discs with BMP-2 were placed in
Transwell inserts. Following the adhesion of the BM-MSCs,
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Figure 1: Role of RGD peptide in cell adhesion during culture of BM-MSCs. (a) Experimental design for plain and modified RGD-alginate
hydrogel. Photographs of human BM-MSCs adhered on the surface of (b) unmodified alginate hydrogel disc and (c) RGD-modified alginate
hydrogel disc 1 day after cell plating. The profiles of BMP-2 release from RGD-modified alginate hydrogel disc with various thicknesses (0.5,
1.0, and 2.0mm) (d) for 24 hours and (e) 10 days. The amount of BMP-2 released from various hydrogel discs was determined by ELISA.The
values represent the mean ± standard deviation (𝑛 = 5).
the cells were cultured with Transwell inserts containing
RGD-modified alginate hydrogel discs with BMP-2 in 𝛼-
MEM for 7 days, with the culture media changed every other
day.
2.5. ALP Assay. To investigate the effects of BMP-2 delivery
mode on BM-MSCs osteogenic differentiation, ALP activity
as an early osteogenic differentiation marker was measured
after 7 days, when cells on alginate hydrogel discswere stained
using an ALP staining kit II (Stemgent, Lexington, MA)
according to the manufacturer’s instructions. The cells on
each alginate gel disc were observed and photographed with
an optical microscope (Nikon, Tokyo, Japan). In addition,
the cells were lysed to quantify ALP activity as described
previously [9]. ALP activity was normalized by the protein
content, which was examined using the BCA protein assay
reagent (Pierce Chemical, Rockford, IL). The BM-MSCs
cultured on RGD-modified alginate without BMP-2 were
used as negative control (Supplementary Figure 2).
2.6. Statistical Analysis. The quantitative data are expressed
asmeans± standard deviations (SD). Statistical analyses were
performed by one-way analysis of variance (ANOVA) with
Statistical Package for the Social Sciences (SPSS) software
(SPSS Inc., Chicago, IL). A value of 𝑝 < 0.05 was considered
statistically significant.
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Figure 2: Schematic representation of culture system on alginate hydrogel disc used to assess the effect of BMP-2 deliverymode on osteogenic
differentiation of human BM-MSCs and photographs of ALP stained human BM-MSCs. (a) Top-down release system, (b) bottom-up release
system, and (c) quantification of ALP activity for BM-MSCs cultured under each mode of delivery.The values represent the mean ± standard
deviation (𝑛 = 3). ∗𝑝 < 0.05 compared with top-down release system at 7 days.
3. Results
3.1. Preparation of RGD-Modified Alginate Hydrogel for
Human BM-MSC Culture. We first performed chemical
conjugation of RGD sequence containing GGGGRGDASSK
peptide into the alginate hydrogel. Because the attachment
capacity of cells is low on alginate hydrogel, it is ideal for
the investigation of RGD influence on adhesion of cells.
Applicability was examined by plating cells (2× 104 cells/cm2)
on an unmodified (control) and RGD-modified alginate
hydrogel disc (Figure 1(a)). After 24 hours of culture, the
unmodified group showed that the cells remained in sus-
pension and were unable to adhere (Figure 1(b)). In contrast,
cell adhesion in the RGD-modified group was favorable
and the attached cells exhibited a fibroblastic morphology
(Figure 1(c)).This result indicated that the peptide containing
RGD was successfully conjugated to the alginate backbone,
resulting in enhancements of cell adhesion on hydrogel disc
that does not naturally possess adhesive properties.
3.2. Analysis of the Kinetics of BMP-2 Release from RGD-
Alginate Hydrogel Discs with Various Thicknesses. Next,
we loaded BMP-2 (2𝜇g/disc) into RGD-modified alginate
hydrogel discs to determine the optimal thickness for releas-
ing BMP-2 effectively into the cell culture plate. The RGD-
modified alginate hydrogel discs with various thicknesses
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Figure 3: A top-down and bottom-up approach applied to a one culture dish. (a) ALP staining and (b) quantification of ALP activity for
BM-MSCs cultured in their respective half. The values represent the mean ± standard deviation (𝑛 = 3). #𝑝 < 0.05 compared with direct
bottom-up release system at 7 days.
(0.5mm, 1.0mm, and 2.0mm) were fabricated and placed
in cell culture plates to test the kinetics of BMP-2 release
from alginate hydrogel discs. The release of BMP-2 from
0.5mm thickness-alginate discs was more rapid than that
from 2.0mm thickness-alginate discs (Figure 1(d)). Almost
all of the BMP-2was released from the alginate hydrogel discs
within the first 10 days (Figure 1(e)). Importantly, the release
of BMP-2 from 2.0mm thickness-alginate hydrogel discs was
sustained for 12 hours. The BMP-2 release rate decreased as
the thickness of alginate hydrogel discs increased. In addition,
with the 0.5mm discs, approximately 90% of the initially
loaded BMP-2 was released over the first 10 days. In contrast,
for the 2.0mm discs, virtually all of the loaded BMP-2 was
released over the first 10 days. The present findings indicate
that the rate of BMP-2 release from alginate hydrogel disc
can be controlled by the thickness of hydrogel disc. A disc
thickness of 2.0mm provides favorable kinetics of BMP-2
release for osteogenic differentiation of stem cells.
3.3. Osteogenic Differentiation of BM-MSCs in Top-Down and
Bottom-Up Release Systems for BMP-2 Delivery. In order to
investigate whether BM-MSCs differentiation was influenced
by the mode of BMP-2 delivery, BM-MSCs were cultured in
a top-down or bottom-up release system (Figure 2). Similar
to standard protocols, the top-down approach was structured
to release BMP-2 into the media through an 8 𝜇m porous
membrane. In contrast, the bottom-up system was set up
in order to make the RGD-alginate hydrogel be in contact
with BM-MSCs during BMP-2 release.This approach utilized
adhesion and proximity in order to force the cells to be more
interactive with the protein. The osteogenic differentiation
of BM-MSCs was analyzed using ALP staining and ALP
activity (mM/protein mg). Results of ALP staining showed
that BM-MSCs cultured in the bottom-up release systemwere
intensively stained compared to those in the top-down release
system (Figures 2(a) and 2(b)), demonstrating that BM-
MSC differentiation into osteogenesis occurred better in the
bottom-up release system than the top-down release system.
Additionally, we analyzed ALP activity (mM/protein mg) in
both release systems.The bottom-up release systemproduced
increased protein level in comparison to the top-down release
system (Figure 2(c)), confirming that differentiation was
more favorable in the bottom-up release system.
Based on these results, we confirmed that differentiation
of stem cells was influenced by the method of release. To fur-
ther investigate this, BM-MSCs in the same culture discs were
divided into two sections consisting of an untreated RGD-
hydrogel and modified BMP2-RGD-hydrogel. As expected,
ALP stains appeared denser in the half of the discs receiving
BMP-2 in a bottom-up manner (Figure 3(a)). However, it is
very likely that BMP-2 released from the bottom-up system
indirectly carried over to the untreated section, which may
have influenced adjacent cells to exhibit signs of differen-
tiation (Figure 3(a), yellow arrow). In addition, measured
ALP activity remained higher in the direct-contact group
regardless of disc division (Figure 3(b)).
4. Discussion
We investigated the effect of the delivery mode of BMP-2
on osteogenic differentiation of human BM-MSCs. The top-
down release system and bottom-up release systemwere used
to investigate the effects of release mode of BMP-2.The main
difference of both systems is how the BMP-2 was transmitted
to the cells.
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Compared to conventional method for BMP-2 treatment
in two-dimensional cell culture, the bottom-up release system
presents several advantages. First, BMP-2 appeared to bind
more rapidly and readily to receptors on cultured stem cells
than BMP-2 released from top-down release system. In top-
down release system (conventional method), BMP-2 released
in the culture medium showed Brownian motion [10]. Thus,
only a small amount of BMP-2 reaches the receptors related
to osteogenic differentiation pathway on the cells. In contrast,
BMP-2 released from bottom-up system may trigger cell
signalsmore efficiently. Although the release profiles of BMP-
2 in both systems are equal, the osteogenic differentiations
of stem cells cultured on bottom-up release system were
superior to those of cultures with top-down release system
(Figure 2). This can be explained by the rapid binding of
BMP-2 released from the alginate hydrogel to receptors on
human BM-MSCs. Second, alginate gel as a BMP-2 reservoir
may play an important role at the delivery site to ensure
their proper biological activity. In this study, half of cell
culture plate is coated with alginate hydrogel containing
BMP-2 (direct system) and half of cell culture plate is coated
with only alginate hydrogel without BMP-2 (indirect system)
(Figure 3). The BMP-2 released from alginate hydrogel in the
direct system rapidly triggered osteogenic differentiation of
stem cells. The direct system induced ALP activity to a much
greater extent than that of indirect system. In contrast, the
osteogenic differentiation of stem cells was interrupted at
indirect culture sites compared to that of direct system. This
indicates that deliverymode of BMP-2may also influence the
efficacy of osteogenic differentiation.
In this study, daily addition of BMP-2 was not used as
a control group. Several studies have reported successful
osteogenic differentiation using various BMP-2 release sys-
tems [11, 12]. In these studies, cells were cultured in culture
plates with BMP-2 added to the culture medium daily as con-
trol group for evaluation of BMP-2 release system. The daily
addition of BMP-2 is based on the assumption that the total
concentration of BMP-2 remains constant. However, actual
amount of BMP-2 in culture media is different as indicated
by BMP-2 release profile. Therefore, conventional control
may be inefficient to test effect on osteogenic differentiation
by delivery mode of BMP-2. Instead, we deliberately used
control groups with equal release profile (top-down release
system) to avoid complicating systemic factors for a more
equal comparison of the two types of BMP-2 delivery mode.
Depending on the type of cell, BMP-2 is involved in the
hedgehog pathway, transforming growth factor-beta signal-
ing pathway, and cytokine-cytokine receptor interaction [13,
14]. Previous studies have reported its involvement in extra-
embryonic endoderm derivation from human embryonic
stem cells and chondrogenic commitment of MSCs as well
as cardiomyocyte contractility [15–17]. While the action of
BMP-2 is relatively extensive, in mesenchymal stromal cells,
it serves as an important factor for osteogenic commitment
in a ligand-dependent manner to activate downstream gene
regulation via SMAD [18] (Figure 4). Thus, we believe that
the enhancement of the osteogenic differentiationwas caused
by the increased osteogenic activity of BM-MSCs that was
presumably triggered by the enhancement of BMP-2 binding
Bottom-up release system
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P
P
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Gene regulation
PSMADsSMADs
P
P
Cofactors
Nuclear membrane
Type II receptor Type I receptor
BMPs
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Figure 4: Schema of osteogenic differentiation through the BMP-
2 signaling pathway. Type I and type II BMP receptors span
the cell membrane and bind extracellular BMP ligand. Ligand
binding to BMP receptor complexes activates signaling through
type II-receptor-mediated phosphorylation of the type I receptor.
In bottom-up release system, the probability of BMP-2 binding to
receptors was maximized during BMP-2 treatment process.
in bottom-up release system. Future studies are needed
to elucidate the molecular mechanisms of BMP-2 binding
effects in the bottom-up release system.
In conclusion, osteogenic differentiation of BM-MSCs
was significantly enhanced in the bottom-up release system
compared to those of the top-down release system. These
results show that the bottom-up release system could serve as
a differentiation stimulator of stem cells. Thus, these findings
could be useful for applications involving stem cell culture or
differentiation studies that aim to advance cell utility in the
field of stem cell therapy.
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